Company: BGLC
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001477932-25-008044
Chunk: 3

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-12
Form: 8-K
Item: Item 7.01
Chunk 3
---
Item 7.01. Regulation FD Disclosure.

On November 12, 2025, the Company issued a press release announcing the transactions described in Item 1.01. A copy of the press release is furnished as Exhibit 99.1.

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statement and Exhibits.